A Pilot Study for the Effect of Human Basal Cell Transplantation in the Treatment of COPD

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1800017862

Enrollment

Unknown

Registered

2018-08-18

Start date

2018-10-01

Completion date

Unknown

Last updated

2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Interventions

Case series:human basal cell transplantation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. aged 40-75 years; 2. COPD, after using bronchodilators, FEV4 weeks; 6. can do fiberbronchoscopy; 7. agree to participate the study; 8. Follow-up on regularly.

Exclusion criteria

Exclusion criteria: 1. Women at childbearing age; 2. SyphilisHIVHBVHCV positive; 3. Cancer; 4. Ashmatuberculosispulmonary embolismpneumothoraxPulmonary Hypertension diffuse parenchymal lung disease; 5. other systematic diseases; 6. WBC<4x10^9/L or WBC <1.5x10^9/L or neutrophils <0.5x10^9/L.

Design outcomes

Primary

Measure	Time frame
DLCO;	—

Secondary

Measure	Time frame
lung-function test;6-minute walk test;CT scan;SGRQ score;mMRC score;CAT score;	—

Countries

China

Contacts

Public ContactQU Jieming

Ruijin Hospital affiliated Shanghai JiaoTong University School of Medicine

jmqu0906@163.com+86 021-64370045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026